Werner coordination chemistry and neurodegeneration.

Area of Science:

• Coordination Chemistry
• Neurodegenerative Diseases
• Metalloproteins

Background:

• Neurodegenerative diseases (Alzheimer's, Parkinson's, prion diseases) present significant global health and financial challenges due to progressive cognitive and physical decline.
• Metal ions are implicated in the pathogenesis of these diseases, potentially by promoting toxic protein aggregation.
• Understanding metal-protein interactions is crucial for developing effective therapeutic interventions.

Purpose of the Study:

• To review the role of Werner coordination chemistry in Alzheimer's, Parkinson's, and prion diseases.
• To discuss the coordination of metal ions, particularly copper(II), with disease-associated metalloproteins (amyloid β, α-synuclein, prion).
• To examine rationally designed metal chelators as potential therapeutic agents by outcompeting deleterious metal binding.

Main Methods:

• Review of existing literature on metal ion coordination environments in neurodegenerative disease-related proteins.
• Analysis of the coordination of metal ions (e.g., copper(II)) by amino acids within amyloid β, α-synuclein, and prion proteins.
• Examination of metal binding affinities and the design principles of metal chelators targeting these interactions.

Main Results:

• Detailed discussion of metal coordination environments within amyloid β, α-synuclein, and prion proteins.
• Presentation of current understanding of metal binding affinities to these disease-associated proteins.
• Overview of various metal chelator designs and their coordination strategies for targeting bio-relevant metal ions.

Conclusions:

• Werner coordination chemistry provides a framework for understanding metal ion involvement in neurodegenerative diseases.
• Metal-protein interactions are key targets for therapeutic intervention.
• The design of effective metal chelators based on coordination principles holds promise for future treatments.